Point72 Asset Management
BNTX icon

Point72 Asset Management’s BioNTech BNTX Stock Holding History

Point72 Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-361,993
Closed -$43M – 2093
2024
Q3 		$43M Sell
361,993
-99,718
-22% -$9.17M 0.11% 217
2024
Q2 		$37.1M Buy
461,711
+341,311
+283% +$31.2M 0.1% 276
2024
Q1 		$11.1M Buy
+120,400
New +$11.5M 0.03% 678
2023
Q1 		– Sell
-302,600
Closed -$45.5M – 2245
2022
Q4 		$45.5M Buy
302,600
+192,600
+175% +$29.6M 0.15% 175
2022
Q3 		$14.8M Buy
+110,000
New +$16.8M 0.06% 400
2022
Q1 		– Sell
-88,700
Closed -$22.9M – 1181
2021
Q4 		$22.9M Buy
+88,700
New +$24.3M 0.09% 304

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Point72 Asset Management's BNTX Position: Q4 2024 in Review

Point72 Asset Management sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 361,993 shares — an estimated $43M sold.

Point72 Asset Management first reported a position in BNTX in Q4 2021 and held it in 6 quarters. The position peaked at $45.5M in Q4 2022. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Point72 Asset Management reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Point72 Asset Management sold 361,993 BioNTech shares in Q4 2024, an estimated $43M.
  • Point72 Asset Management first reported a position in BioNTech in Q4 2021 and held it in 6 quarters.
  • Point72 Asset Management's BioNTech position peaked at $45.5M in Q4 2022.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.